+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hormone Replacement Therapy Market 2024-2028

  • PDF Icon

    Report

  • 161 Pages
  • January 2024
  • Region: Global
  • TechNavio
  • ID: 5923863
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The hormone replacement therapy market is forecasted to grow by USD 8.44 bn during 2023-2028, accelerating at a CAGR of 6.67% during the forecast period. The report on the hormone replacement therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by development of innovative hormone replacement therapy products, increasing prevalence of hormonal disorders, and growing global healthcare expenditure.

The hormone replacement therapy market is segmented as below:

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Type

  • Estrogen and progesterone replacement therapy
  • Thyroid hormone replacement therapy
  • HGH replacement therapy
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the expanding applications of hormone replacement therapy as one of the prime reasons driving the hormone replacement therapy market growth during the next few years. Also, cultural shifts in attitudes toward menopause and rising focus on preventive healthcare will lead to sizable demand in the market.

The report on the hormone replacement therapy market covers the following areas:

  • Hormone replacement therapy market sizing
  • Hormone replacement therapy market forecast
  • Hormone replacement therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hormone replacement therapy market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Besins Healthcare Monaco, Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., Hisamitsu Pharmaceutical Co. Inc., Lupin Ltd., Merck KGaA, Mithra Pharmaceuticals SA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the hormone replacement therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global hormone replacement therapy market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global hormone replacement therapy market 2018 - 2022 ($ billion)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ billion)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2023-2028 (%)
Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028
Exhibit 52: Chart on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
7.4 Thyroid hormone replacement therapy - Market size and forecast 2023-2028
Exhibit 56: Chart on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
7.5 HGH replacement therapy - Market size and forecast 2023-2028
Exhibit 60: Chart on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
Exhibit 68: Market opportunity by Type ($ billion)
Exhibit 69: Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 119: Abbott Laboratories - Overview
Exhibit 120: Abbott Laboratories - Business segments
Exhibit 121: Abbott Laboratories - Key news
Exhibit 122: Abbott Laboratories - Key offerings
Exhibit 123: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 124: AbbVie Inc. - Overview
Exhibit 125: AbbVie Inc. - Product / Service
Exhibit 126: AbbVie Inc. - Key news
Exhibit 127: AbbVie Inc. - Key offerings
12.5 Amgen Inc.
Exhibit 128: Amgen Inc. - Overview
Exhibit 129: Amgen Inc. - Product / Service
Exhibit 130: Amgen Inc. - Key offerings
12.6 Bayer AG
Exhibit 131: Bayer AG - Overview
Exhibit 132: Bayer AG - Business segments
Exhibit 133: Bayer AG - Key news
Exhibit 134: Bayer AG - Key offerings
Exhibit 135: Bayer AG - Segment focus
12.7 Besins Healthcare Monaco
Exhibit 136: Besins Healthcare Monaco - Overview
Exhibit 137: Besins Healthcare Monaco - Product / Service
Exhibit 138: Besins Healthcare Monaco - Key offerings
12.8 Eli Lilly and Co.
Exhibit 139: Eli Lilly and Co. - Overview
Exhibit 140: Eli Lilly and Co. - Product / Service
Exhibit 141: Eli Lilly and Co. - Key news
Exhibit 142: Eli Lilly and Co. - Key offerings
12.9 Endo International Plc
Exhibit 143: Endo International Plc - Overview
Exhibit 144: Endo International Plc - Business segments
Exhibit 145: Endo International Plc - Key news
Exhibit 146: Endo International Plc - Key offerings
Exhibit 147: Endo International Plc - Segment focus
12.10 F. Hoffmann La Roche Ltd.
Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Merck KGaA
Exhibit 153: Merck KGaA - Overview
Exhibit 154: Merck KGaA - Business segments
Exhibit 155: Merck KGaA - Key news
Exhibit 156: Merck KGaA - Key offerings
Exhibit 157: Merck KGaA - Segment focus
12.12 Mithra Pharmaceuticals SA
Exhibit 158: Mithra Pharmaceuticals SA - Overview
Exhibit 159: Mithra Pharmaceuticals SA - Product / Service
Exhibit 160: Mithra Pharmaceuticals SA - Key offerings
12.13 Novartis AG
Exhibit 161: Novartis AG - Overview
Exhibit 162: Novartis AG - Business segments
Exhibit 163: Novartis AG - Key offerings
Exhibit 164: Novartis AG - Segment focus
12.14 Novo Nordisk AS
Exhibit 165: Novo Nordisk AS - Overview
Exhibit 166: Novo Nordisk AS - Business segments
Exhibit 167: Novo Nordisk AS - Key offerings
Exhibit 168: Novo Nordisk AS - Segment focus
12.15 Pfizer Inc.
Exhibit 169: Pfizer Inc. - Overview
Exhibit 170: Pfizer Inc. - Product / Service
Exhibit 171: Pfizer Inc. - Key news
Exhibit 172: Pfizer Inc. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 178: Viatris Inc. - Overview
Exhibit 179: Viatris Inc. - Business segments
Exhibit 180: Viatris Inc. - Key news
Exhibit 181: Viatris Inc. - Key offerings
Exhibit 182: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 183: Inclusions checklist
Exhibit 184: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 185: Currency conversion rates for US$
13.4 Research methodology
Exhibit 186: Research methodology
Exhibit 187: Validation techniques employed for market sizing
Exhibit 188: Information sources
13.5 List of abbreviations
Exhibit 189: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global hormone replacement therapy market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Distribution Channel ($ billion)
Exhibits 47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 48: Chart on Type - Market share 2023-2028 (%)
Exhibits 49: Data Table on Type - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Type
Exhibits 51: Data Table on Comparison by Type
Exhibits 52: Chart on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Data Table on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Chart on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 66: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 68: Market opportunity by Type ($ billion)
Exhibits 69: Data Table on Market opportunity by Type ($ billion)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 111: Market opportunity By Geographical Landscape ($ billion)
Exhibits 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 113: Impact of drivers and challenges in 2023 and 2028
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: Abbott Laboratories - Overview
Exhibits 120: Abbott Laboratories - Business segments
Exhibits 121: Abbott Laboratories - Key news
Exhibits 122: Abbott Laboratories - Key offerings
Exhibits 123: Abbott Laboratories - Segment focus
Exhibits 124: AbbVie Inc. - Overview
Exhibits 125: AbbVie Inc. - Product / Service
Exhibits 126: AbbVie Inc. - Key news
Exhibits 127: AbbVie Inc. - Key offerings
Exhibits 128: Amgen Inc. - Overview
Exhibits 129: Amgen Inc. - Product / Service
Exhibits 130: Amgen Inc. - Key offerings
Exhibits 131: Bayer AG - Overview
Exhibits 132: Bayer AG - Business segments
Exhibits 133: Bayer AG - Key news
Exhibits 134: Bayer AG - Key offerings
Exhibits 135: Bayer AG - Segment focus
Exhibits 136: Besins Healthcare Monaco - Overview
Exhibits 137: Besins Healthcare Monaco - Product / Service
Exhibits 138: Besins Healthcare Monaco - Key offerings
Exhibits 139: Eli Lilly and Co. - Overview
Exhibits 140: Eli Lilly and Co. - Product / Service
Exhibits 141: Eli Lilly and Co. - Key news
Exhibits 142: Eli Lilly and Co. - Key offerings
Exhibits 143: Endo International Plc - Overview
Exhibits 144: Endo International Plc - Business segments
Exhibits 145: Endo International Plc - Key news
Exhibits 146: Endo International Plc - Key offerings
Exhibits 147: Endo International Plc - Segment focus
Exhibits 148: F. Hoffmann La Roche Ltd. - Overview
Exhibits 149: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 150: F. Hoffmann La Roche Ltd. - Key news
Exhibits 151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 152: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 153: Merck KGaA - Overview
Exhibits 154: Merck KGaA - Business segments
Exhibits 155: Merck KGaA - Key news
Exhibits 156: Merck KGaA - Key offerings
Exhibits 157: Merck KGaA - Segment focus
Exhibits 158: Mithra Pharmaceuticals SA - Overview
Exhibits 159: Mithra Pharmaceuticals SA - Product / Service
Exhibits 160: Mithra Pharmaceuticals SA - Key offerings
Exhibits 161: Novartis AG - Overview
Exhibits 162: Novartis AG - Business segments
Exhibits 163: Novartis AG - Key offerings
Exhibits 164: Novartis AG - Segment focus
Exhibits 165: Novo Nordisk AS - Overview
Exhibits 166: Novo Nordisk AS - Business segments
Exhibits 167: Novo Nordisk AS - Key offerings
Exhibits 168: Novo Nordisk AS - Segment focus
Exhibits 169: Pfizer Inc. - Overview
Exhibits 170: Pfizer Inc. - Product / Service
Exhibits 171: Pfizer Inc. - Key news
Exhibits 172: Pfizer Inc. - Key offerings
Exhibits 173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 177: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 178: Viatris Inc. - Overview
Exhibits 179: Viatris Inc. - Business segments
Exhibits 180: Viatris Inc. - Key news
Exhibits 181: Viatris Inc. - Key offerings
Exhibits 182: Viatris Inc. - Segment focus
Exhibits 183: Inclusions checklist
Exhibits 184: Exclusions checklist
Exhibits 185: Currency conversion rates for US$
Exhibits 186: Research methodology
Exhibits 187: Validation techniques employed for market sizing
Exhibits 188: Information sources
Exhibits 189: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global hormone replacement therapy market: Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Besins Healthcare Monaco, Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., Hisamitsu Pharmaceutical Co. Inc., Lupin Ltd., Merck KGaA, Mithra Pharmaceuticals SA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is expanding applications of hormone replacement therapy.'

According to the report, one of the major drivers for this market is the development of innovative hormone replacement therapy products.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • Besins Healthcare Monaco
  • Eli Lilly and Co.
  • Endo International Plc
  • F. Hoffmann La Roche Ltd.
  • Hisamitsu Pharmaceutical Co. Inc.
  • Lupin Ltd.
  • Merck KGaA
  • Mithra Pharmaceuticals SA
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Global Hormone Replacement Therapy Market by Type (Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy), Route of Administration (Oral, Parenteral, Transdermal) - Forecast 2024-2030 - Product Image

Global Hormone Replacement Therapy Market by Type (Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy), Route of Administration (Oral, Parenteral, Transdermal) - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Hormone Replacement Therapy Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Hormone Replacement Therapy Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 180 Pages
  • Global
From
Global Hormone Replacement Therapy Market Report and Forecast 2023-2031 - Product Image

Global Hormone Replacement Therapy Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 123 Pages
  • Global
From
Hormone Replacement Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Hormone Replacement Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 93 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.